Group 1 - The company has received the approval notice for the supplement application of its antiviral tablet from the National Medical Products Administration [1] - The antiviral tablet is classified as a traditional Chinese medicine and is produced by the company, with the production site and quality standards remaining unchanged [1][2] - The approval of this product is expected to enhance the company's product line and market competitiveness, positively impacting future performance [3] Group 2 - The antiviral tablet contains ingredients such as Ban Lan Gen, Shi Gao, Di Huang, and others, and is primarily used for treating wind-heat colds, upper respiratory infections, and influenza [2] - The approval process followed the relevant regulations under the Drug Administration Law of the People's Republic of China, confirming compliance with registration requirements [1]
吉林省西点药业科技发展股份有限公司关于公司抗病毒片获得药品补充申请批准通知书的公告